HURA
Income statement / Annual
Last year (2023), TuHURA Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, TuHURA Biosciences, Inc.'s net income was -$29.32 M.
See TuHURA Biosciences, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
06/30/2021 |
06/30/2020 |
06/30/2019 |
06/30/2018 |
06/30/2017 |
06/30/2016 |
06/30/2015 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$32,000.00
|
$10,000.00
|
$16,348.00
|
$24,528.00
|
$16,683.00
|
$10,288.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
-$32,000.00
|
-$10,000.00
|
-$16,348.00
|
-$24,528.00
|
-$16,683.00
|
-$10,288.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$9.40 M
|
$7.93 M
|
$4.88 M
|
$11.82 M
|
$3.63 M
|
$3.66 M
|
$7.13 M
|
$5.00 M
|
$3.36 M
|
$2.56 M
|
| General & Administrative Expenses |
$4.14 M
|
$2.01 M
|
$2.38 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$4.14 M
|
$2.01 M
|
$2.38 M
|
$9.73 M
|
$4.50 M
|
$4.72 M
|
$4.02 M
|
$3.30 M
|
$2.84 M
|
$2.17 M
|
| Other Expenses |
$16.22 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$29.76 M
|
$9.93 M
|
$7.25 M
|
$21.54 M
|
$8.13 M
|
$8.38 M
|
$11.15 M
|
$8.30 M
|
$6.20 M
|
$4.72 M
|
| Cost And Expenses |
$29.76 M
|
$9.93 M
|
$7.25 M
|
-$21.57 M
|
-$8.14 M
|
-$8.40 M
|
-$11.17 M
|
-$8.32 M
|
-$6.21 M
|
-$4.72 M
|
| Interest Income |
$89,673.00
|
$57,351.00
|
$0.00
|
$0.00
|
$75,000.00
|
$60,704.00
|
$33,243.00
|
$457.00
|
$108.00
|
$363.00
|
| Interest Expense |
$18,688.00
|
$0.00
|
$629,286.00
|
$120,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$2,091.00
|
| Depreciation & Amortization |
$177,377.00
|
$373,093.00
|
$380,694.00
|
$32,000.00
|
$10,000.00
|
$16,348.00
|
$24,528.00
|
$16,683.00
|
$10,288.00
|
$378,972.00
|
| EBITDA |
-$29.12 M |
-$9.56 M |
-$6.01 M |
-$38.15 M |
-$9.12 M |
-$8.03 M |
-$11.11 M |
-$8.07 M |
-$8.85 M |
-$4.35 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$447,894.00
|
$566,338.00
|
$238,472.00
|
-$16.73 M
|
-$982,000.00
|
$350,275.00
|
$36,351.00
|
$239,065.00
|
-$2.65 M
|
$376,886.00
|
| Income Before Tax |
-$29.32 M
|
-$9.37 M
|
-$7.02 M
|
-$38.30 M
|
-$9.13 M
|
-$8.05 M
|
-$11.14 M
|
-$8.08 M
|
-$8.86 M
|
-$4.35 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$1.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$29.32 M
|
-$9.37 M
|
-$7.02 M
|
-$38.30 M
|
-$9.13 M
|
-$8.05 M
|
-$11.14 M
|
-$8.08 M
|
-$8.86 M
|
-$4.35 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.12 |
-202.39 |
-0.17 |
-2806.03 |
-1532 |
-5524.99 |
-9491.43 |
-12888.09 |
-14550.5 |
-7994.84 |
| EPS Diluted |
-0.12 |
-202.39 |
-0.17 |
-2806.03 |
-1532 |
-5524.99 |
-9491.43 |
-12888.09 |
-14550.5 |
-7994.84 |
| Weighted Average Shares Out |
$68.01 M
|
$46,285.00
|
$42.03 M
|
$14,791.00
|
$5,968.00
|
$1,471.25
|
$1,192.08
|
$688.40
|
$625.63
|
$543.82
|
| Weighted Average Shares Out Diluted |
$68.01 M
|
$46,285.00
|
$42.03 M
|
$14,791.00
|
$5,968.00
|
$1,471.25
|
$1,192.08
|
$688.40
|
$625.63
|
$543.82
|
| Link |
|
|
|
|
|
|
|
|
|
|
